DKLM 2025: Study analyzes comorbidities in asthma and COPD in clinical data
In a real-world analysis, researchers have investigated the frequency and patterns of asthma and COPD as main and secondary diagnoses in inpatient care. The CALM-QE project evaluates routine data from the years 2006 to 2025 in order to determine care profiles and influencing factors and to create the basis for predictive models.
Asthma and COPD are among the most common chronic respiratory diseases worldwide and often occur in the context of internal diseases such as pneumonia or heart failure. The retrospective study includes patients aged 18 years and older with corresponding ICD-10 diagnoses and takes into account demographic data, comorbidities and combinations of major and secondary diagnoses.

Among the cases analyzed, 339 involved asthma and 3218 COPD. The median age for asthma was 50 years with a proportion of women of over 67 percent, and for COPD 69 years with around 42 percent women. The age distribution showed asthma in younger patients and COPD in older patients. Comorbidities such as hypertension, diabetes or pneumonia occurred significantly more frequently in COPD, while diseases such as gastroesophageal reflux disease or acute bronchitis were more dominant in asthma.
Case numbers evolved over the years, with more stable comorbidity patterns in COPD and more volatile patterns in asthma. The study highlights the need for personalized care and plans to integrate other data such as laboratory values and outcomes. Limitations include retrospective design and potential coding errors in the ICD data.
Important details can be seen as posters at the DKLM 2025 in Leipzig. Interested media can receive the poster in advance in compliance with the strict embargo period of 23.10.2025 / 00:01 and presentation of a valid press card. To do so, send us your enquiry including a copy of your press card to: redaktion@medlabportal.de
The German Congress of Laboratory Medicine (DKLM) 2025 promises exciting insights into the interface between science and clinical practice. Under the motto “Science for Precision Medicine”, the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) and the Umbrella Association for Technologists and Analysts in Medicine Germany (DVTA) invite experts from research, clinics and industry to meet on October 23 and 24 at the Congress Center Leipzig (CCL). The two-day event is aimed at laboratory physicians, biomedical analysts and decision-makers to discuss current advances in diagnostics and strengthen networks. The ceremonial opening of the congress will take place on 22 October with the presentation of the MedLabAwards in the Salles de Pologne.
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.